Here are three points:
1. The grants total $155,000.
2. The funds will help Bacterin International, a Xtant wholly-owned subsidiary, expand its orthobiologic process facility.
3. The grants will specifically contribute to new processing equipment, new job creation and job training.
More articles on devices:
Spinal Elements hits 50 US patents — 5 things to know
RBC Capital increases Stryker price target to $120 — 5 key facts
21 spine devices receive FDA 510(k) clearance in March
